InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Yeshwant Krishna, Director. Officer active across 1 company, notably Verve Therapeutics, Inc.. In total, 6 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €16.5m. History available since 31 October 2022. The latest transaction was disclosed on 1 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Yeshwant Krishna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
1,800,000 shares@ US$10.00100.0% of flowCommon StockSEC:0000950170-23-068199:0
Canonical exit: 29 Feb 2024 (T+90)
48,583 shares0Common StockSEC:0000899243-22-035380:0
28,651 shares0Common StockSEC:0000899243-22-035228:0
53,697 shares0Common StockSEC:0000899243-22-034842:0
6,320,905 sharesCommon StockSEC:0000899243-21-025307
6,320,905 sharesCommon StockSEC:0000899243-21-025307:0
6 of 6 declarations
About Yeshwant Krishna
Krishna Yeshwant is a Director at Verve Therapeutics, Inc. In this role, he participates in the strategy and governance of the company. His experience in the biotechnology field is valuable in guiding strategic decisions and supporting innovation at Verve Therapeutics, Inc.
